Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Case Report
Consensus Statement
Editorial
Erratum
Guest Editorial
History
Image
Images in Clinical Practice
Invited Commentary
JSSTD Symposium
Letter to Editor
Letter to the Editor
Letter to the Editor - Study Letter
Net Case
Net Image
Net Letter
Original Article
Resident’s Page
Review Article
Study Letter
Study Letter Case Series
View/Download PDF

Translate this page into:

Letter to the Editor
3 (
1
); 94-95
doi:
10.25259/JSSTD_51_2020

Skin as a mirror for coronavirus disease

Department of Dermatology, Usha Memorial Skin and Eye Hospital, Bilaspur, Chhattisgarh, India
Corresponding author: Daniel Henry,Department of Dermatology, Usha Memorial Skin and Eye Hospital, Bilaspur, Chhattisgarh, India. danielhenry21@yahoo.com
Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

How to cite this article: Henry D, Henry D. Skin as a mirror for coronavirus disease. J Skin Sex Transm Dis 2021;3(1):94-5.

Sir,

With the rise in number of coronavirus disease (COVID-19)-positive patients in the country, we are seeing varying manifestations of the disease. Here, we report a young adult who presented with erythematous inguinal rash as one of the initial manifestations of COVID-19 infection.

A 20-year-old man came to our hospital with complaints of asymptomatic rash of groin, fever, difficulty in breathing and vomiting, of 2 days duration. His temperature, pulse rate, and respiratory rate were 38°C, 80/min, and 18/min, respectively. He denied history of intake of any medication before the onset of the disease. He had no recent contact with any allergen and there was no history of any insect bite. Physical examination revealed erythematous maculopapular rash involving the inguinal area on both sides [Figure 1]. Hence, we decided to investigate and advised complete hemogram and chest X-ray. His total leukocyte count was 7100 cells/mm3 (polymorphs 58%, lymphocytes 36%, eosinophil 3%, and monocytes 3%). His serum levels of C-reactive protein, D dimer, and lactate dehydrogenase were 58.6 mg/L, 517.35 ng/ml, and 368.12 U/L, respectively. Chest X-ray showed right lower zone pneumonitis. We gave moisturizer and topical steroid for the rash along with antioxidant tablets. The patient was referred to regional COVID hospital where he was diagnosed as a case of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (COVID-19).

Figure 1:: Erythematous maculopapular rash involving the inguinal area in a patient with COVID-19 disease.

Skin manifestations are not very common in COVID-19 infection. The common clinical features documented in studies on COVID-19 pneumonia patients are fever, dry cough, shortness of breath, myalgia, and fatigue.[1] The important case study of dermatological manifestations of COVID-19 published by Recalcati,[2] in Lombardy, Italy, included 88 patients. In this study, 20.4% of the confirmed COVID-19 patients (18/88) had developed cutaneous manifestations. It was found that most cutaneous presentations were erythematous rash (14/18, 77.8%) with a few cases of urticaria (3/18, 16.7%) and vesicle formation (1/18, 5.6%). A similar case of inguinal rash was reported by Karaca, et al. in a 58 year old male patient with COVID-19 infection.[3] The rash was asymptomatic, which was similar to our case, but was unilateral. They did a skin biopsy that showed extravasated red blood cells in the superficial dermis along with peripheral lymphocytic dermatitis around the vessels extending to the middle layers of the dermis. SARS-CoV-2 uses angiotensin-converting enzyme 2 (ACE2) receptors to enter the cell. The expression of ACE2 receptors in the skin and blood vessels has been shown to correlate with the immune status of the patients, although the cutaneous effects of the infection have not been clearly delineated yet.[4] Besides, no clear-cut evidence exists to suggest that the degree of cutaneous involvement is related to the severity of the disease.[5] Studies have reported cutaneous involvement in 0.2%–20% of COVID-19 patients.[6] Two different mechanisms are primarily suggested to explain the cutaneous lesions. The first is the immune response to the viral infection that manifests with morbilliform rash, petechial rash, erythematous-to-purpuric coalescing macules, widespread urticaria, and varicella-like vesicles. The other one is associated with vasculopathy, manifesting with peripheral cyanosis with bullae and dry gangrene, transient unilateral livedo reticularis, and red papules on fingers resembling chilblains.[7] Dermatologists can play a major role in the diagnosis of SARS-CoV-2 infections. Knowing the cutaneous manifestation of COVID-19 may help in early diagnosis and proper treatment of the patient.

Declaration of patient consent

Patient’s consent not required as patients identity is not disclosed or compromised.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

References

  1. , . A case of COVID-19 pneumonia in a young male with full body rash as a presenting symptom. Clin Pract Cases Emerg Med. 2020;4:219-21.
    [CrossRef] [Google Scholar]
  2. . Cutaneous manifestations in COVID-19: A first perspective. J Eur Acad Dermatol Venereol. 2020;34:e212-3.
    [CrossRef] [Google Scholar]
  3. , , . A unilateral purpuric rash in a patient with COVID-19 infection. Dermatol Ther. 2020;33:e13798.
    [CrossRef] [PubMed] [Google Scholar]
  4. , , , . Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Poverty. 2020;9:45.
    [CrossRef] [PubMed] [Google Scholar]
  5. , , , , . Cutaneous manifestations in the current pandemic of coronavirus infection disease (COVID 2019) An Pediatr (Engl Ed). 2020;92:374-5.
    [CrossRef] [PubMed] [Google Scholar]
  6. , , , , , . Comment on cutaneous manifestations in COVID-19: A first perspective by Recalcati S. J Eur Acad Dermatol Venereol. 2020;34:e299-300.
    [CrossRef] [PubMed] [Google Scholar]
  7. , , . Cutaneous manifestations in COVID-19: Lessons learned from current evidence. J Am Acad Dermatol. 2020;83:e57-60.
    [CrossRef] [PubMed] [Google Scholar]

Fulltext Views
1,304

PDF downloads
221
View/Download PDF
Download Citations
BibTeX
RIS
Show Sections